Clinical aspects of the use of gamma linolenic acid in systemic sclerosis

Acta Dermato-Venereologica

Volumn 76, Issue 2, 1996, Pages 144-146

  Stainforth, Julia M ^a,b   Layton, Alison M ^a   Goodfield, M J D ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

laser Doppler flowmetry; prostaglandins; vascular reactivity

Indexed keywords

ESSENTIAL FATTY ACID; GAMMA LINOLENIC ACID; PLACEBO; PRIMROSE OIL;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN BLOOD FLOW; SYSTEMIC SCLEROSIS;

ADULT; AGED; BLOOD FLOW VELOCITY; DOUBLE-BLIND METHOD; FEMALE; GAMMA-LINOLENIC ACID; HUMANS; LASER-DOPPLER FLOWMETRY; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT SATISFACTION; SCLERODERMA, SYSTEMIC; TREATMENT OUTCOME;

EID: 0029865651     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Jayson MV. Systemic sclerosis - a microvascular disorder? J Royal Soc Med 1983; 76: 635-642.
2. Kahaleh MB, Sherer GK, LeRoy EC. Endothelial injury in scleroderma. J Exp Med 1979; 149: 1326-1335.
3. Rowell NR. Systemic sclerosis. The Watson Smith Lecture 1984. J Royal Coll Phys Lond 1985; 19: 23-30.
4. Martin MFR, Dowd PM, Ring EFJ, Cooke ED, Dieppe PA, Kirby JD. Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis. Ann Rheum Dis 1981; 40: 350-354.
5. Fisher JM, Donegan DR, Leon H, Willis AL. Effects of prostaglandins and their precursors in some tests of haemostatic function. Progr Lipid Res 1982; 20: 799-805.
6. Scholkens BA, Gehring D, Schlotte V, Weithmann U. Evening primrose oil, a dietary prostaglandin precursor, diminishes vascular reactivity to renin and angiotensin II in rats. Prost Leuk Med 1982; 8: 273-275.
7. Begent NA, Born GVR, Shafi S, Thorngren M. Increased bleeding times associated with decreased vascular contractility in rats fed polyunsaturated lipids. J Physiol 1984; 349: 69P.
8. Dyerberg J, Bang HO. Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet 1979; 2: 433-435.
9. Horrobin DF. The regulation of prostaglandin biosynthesis: negative feed back mechanisms and the selective control of formation of 1 and 2 series prostaglandins: relevance to inflammation and immunity. Med Hypotheses 1980; 6: 687-709.
10. Belch JJF, Shaw B, O'Dowd A, Saniabadi A, Leiberman P, Sturrock RD, et al. Evening primrose oil (Efamol) in the treatment of Raynaud's phenomenon: a double blind study. Thromb Haemost 1985; 54: 490-494.
11. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23: 581-590.
12. Goodfield MJD, Hume A, Rowell NR. The effect of simple warming procedures on finger blood flow in systemic sclerosis. Br J Dermatol 1988; 118: 661-668.
13. Hovius SE, van Adrichem LN, Mulder HD, van Strik R, van der Meulen JC. Comparison of laser Doppler flowmetry and thermometry in the postoperative monitoring of replantations. J Hand Surg [Am] 1995; 20: 88-93.
14. Fischer JC, Parker PM, Shaw WW. Comparison of two laser Doppler flowmeters for the monitoring of dermal blood flow. Microsurgery 1983; 4: 164-170.
15. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-205.